doi: 10.3389/fmicb.2021.698169 224 PushpakumarS.RenL.KunduS.GamonA.TyagiS
[5] Liver enzymes (ALT, AST): GLP-1s are generally safe for the liver and are even being studied in fatty liver disease
L-carnitine supplements have been trending quite a lot recently
The most commonly reported side effects of GLP-1 receptor agonists, documented across multiple large randomized controlled clinical trials enrolling thousands of participants, are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort, all of which are most commonly reported during the initial titration phase when dosage is being escalated from a low starting point toward a therapeutic target and the body is still adapting to the mechanism of action
Hypertrophy + hyperplasia Animal-model research shows IGF-1 LR3 drives both fibre growth (hypertrophy) and new fibre formation (hyperplasia) - distinct from most anabolic agents
As the industry refines its standards, lasting success depends on user-centered design and consistent delivery